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The synapse between olivocochlear (OC) neurons and cochlear mechanosensory hair cells is cholinergic, fast, and inhibitory. The inhib-
itory sign of this cholinergic synapse is accounted for by the activation of Ca2-permeable postsynaptic 910 nicotinic receptors
coupled to the opening of hyperpolarizing Ca2-activated small-conductance type 2 (SK2)K channels. Acetylcholine (ACh) release at
this synapse is supported by both P/Q- and N-type voltage-gated calcium channels (VGCCs). Although the OC synapse is cholinergic, an
abundantOCGABA innervation ispresent along themammaliancochlea.The roleof thisneurotransmitter at theOCefferent innervation,
however, is for themost part unknown.We show that GABA fails to evoke fast postsynaptic inhibitory currents in apical developing inner
andouter hair cells.However, electrical stimulationofOCefferent fibers activates presynapticGABAB(1a,2) receptors [GABAB(1a,2)Rs] that
downregulate the amount of ACh released at the OC–hair cell synapse, by inhibiting P/Q-type VGCCs. We confirmed the expression of
GABABRs at OC terminals contacting the hair cells by coimmunostaining for GFP and synaptophysin in transgenic mice expressing
GABAB1–GFP fusion proteins. Moreover, coimmunostaining with antibodies against the GABA synthetic enzyme glutamic acid decar-
boxylase and synaptophysin support the idea that GABA is directly synthesized at OC terminals contacting the hair cells during develop-
ment. Thus, we demonstrate for the first time a physiological role for GABA in cochlear synaptic function. In addition, our data suggest
that the GABAB1a isoform selectively inhibits release at efferent cholinergic synapses.
Introduction
In the mammalian inner ear, hair cells convert sound into elec-
trical signals that are conveyed to the CNS via peripheral afferent
neurons. In addition, hair cells and sensory neurons receive an
efferent feedback from the olivocochlear (OC) system (Guinan,
2011). This system comprises the following two groups of fibers:
the medial OC (MOC) fibers, whose main targets are the outer
hair cells (OHCs); and the lateral OC (LOC) fibers, mainly tar-
geting the dendrites of type I neurons that innervate inner hair
cells (IHCs; Liberman et al., 1990). TheMOC system is an inhib-
itory pathway that regulates, via the MOC–OHC synapse, the
cochlear amplifier. During development, IHCs are also tran-
siently innervated by MOC fibers (Glowatzki and Fuchs, 2000;
Simmons, 2002; Katz et al., 2004; Guinan, 2011; Roux et al.,
2011). Before the onset of hearing, IHCs fire spontaneous action
potentials that drive the release of glutamate at the first auditory
synapse (Beutner and Moser, 2001). These MOC–IHC synapses
might therefore play a role in the establishment of the auditory
pathway, by regulating the firing frequency of IHCs during this
developmental period (Glowatzki and Fuchs, 2000; Goutman et
al., 2005; Johnson et al., 2011).
At MOC–hair cell synapses, acetylcholine (ACh) activates
calcium-permeable910 nicotinic ACh receptors (nAChRs; El-
goyhen et al., 2001) functionally coupled to the opening of
calcium-dependent small-conductance type 2 (SK2) K chan-
nels that hyperpolarize the hair cells (Dulon and Lenoir, 1996;
Glowatzki and Fuchs, 2000; Oliver et al., 2000; Katz et al., 2011).
ACh release is mediated by the activation of N- and P/Q-type
voltage-gated calcium channel (VGCCs; Zorrilla de SanMartín et
al., 2010).
Although ACh is the main MOC neurotransmitter, a robust
GABAergic innervation is seen both in the IHC and OHC areas
(Fex and Altschuler, 1986; Vetter et al., 1991; Eybalin, 1993; Mai-
Received June 17, 2013; revised July 31, 2013; accepted Aug. 20, 2013.
Author contributions: C.W., A.B.E., and E.K. designed research; C.W., J.Z.d.S.M., J.B., M.E.G.-C., and A.V.T. per-
formed research; C.W., P.A.F., A.B.E., and E.K. analyzed data; C.W., B.B., A.B.E., and E.K. wrote the paper.
This work was supported by research grants from the University of Buenos Aires to E.K. (UBACYT 2008-10;
2011-14) andA.B.E. (UBACYT2008-2010); fromAgenciaNacional de Promocio´n Científica y Tecnolo´gica (Argentina)
to A.B.E. and E.K.; from Howard Hughes Medical Institute International Scholars Program to A.B.E.; from National
Institutes of Health (R01 DC001508) to P.A.F. and A.B.E.; from the National Organization for Hearing Research to
M.E.G.-C.; and from the Swiss National Science Foundation (3100A0-117816) to B.B.
*A.B.E. and E.K. contributed equally to this work.
Correspondence should be addressed to Eleonora Katz, Instituto de Investigaciones en Ingeniería Gene´tica y
Biología Molecular (INGEBI-CONICET), Vuelta de Obligado 2490, 1428 Buenos Aires, Argentina. E-mail:
eleokatz@gmail.com.
DOI:10.1523/JNEUROSCI.2554-13.2013
Copyright © 2013 the authors 0270-6474/13/3315477-11$15.00/0
The Journal of Neuroscience, September 25, 2013 • 33(39):15477–15487 • 15477
son et al., 2003). Moreover, in adult mice, GABA colocalizes with
ACh in almost all efferent terminals of the OC system (Maison et
al., 2003). The phenotypic analysis ofmice lackingGABAA recep-
tor subunits has suggested that the GABAergic component of the
OC system contributes to the long-termmaintenance of hair cells
and neurons in the inner ear (Maison et al., 2006). Furthermore,
the analysis of GABAB1 knock-out mice has indicated that
GABAergic signaling might be required for normal OHC ampli-
fier function at low sound levels andOHC responses to high-level
sound (Maison et al., 2009). In addition, GABA-mediated
changes in the stiffness and motility of OHCs have been reported
(Zenner et al., 1992; Batta et al., 2004). Although one study has
reported that OHCs hyperpolarize in the presence of GABA (Gitter
andZenner, 1992), suggestiveof the existenceofpostsynapticGABA
receptors, the site of action and the physiological effects of GABA at
MOC–hair cell synapses are poorly understood.
To gain insight into the role of GABA in synaptic transmission
at the mammalian peripheral auditory system, we searched for a
postsynaptic effect of GABA at IHCs andOHCs of the developing
mouse cochlea. Moreover, we studied the effect of GABABR-
selective compounds on transmitter release at mouseMOC–hair
cell synapses. Using pharmacological and electrophysiological
approaches, together with mutant mouse lines lacking specific
GABABR subtypes, we demonstrate for the first time a physiolog-
ical role forGABA inOC efferent synaptic transmission.Whereas
GABA does not elicit IPSCs, activation of presynaptic GABABRs
inhibits the release of ACh fromOC terminals. Thus, we demon-
strate that the release of GABA at an inhibitory mammalian cho-
linergic synapse activates presynaptic GABABRs to downregulate
the release of ACh.
Materials andMethods
Animal procedures and isolation of the organ of Corti. Procedures for
preparing and recording from the postnatal mouse organ of Corti were
essentially identical to those published previously (Glowatzki and Fuchs,
2000; Katz et al., 2004). Briefly, mid-apical turns of the organ of Corti
were excised from BalbCGABABRmutant and control mice of either sex
between postnatal day 9 (P9; day of birth was considered to be P0) and
P11 for IHC recording. P12–P16 mice were used for OHC recordings.
We chose P9–P11 mice for IHC recordings because ACh sensitivity has
been shown to be maximal at this stage (Katz et al., 2004; Roux et al.,
2011). To study theMOC–OHC synapse, we used P12–P16mice because
OHCs start to be innervated by the MOC fibers at the second postnatal
week (Simmons, 2002). In addition, at P12–P16 the cochlear amplifier
(OHC electromotility) is already functional (He and Dallos, 1999).
The cochlear preparationswere placed in the chamber for electrophys-
iological recordings, mounted under an Zeiss Axioskop microscope and
viewed with differential interference contrast using a 40 water-
immersion objective and a camera with contrast enhancement (Dage-
MTI). All experimental protocols were performed in accordancewith the
American Veterinary Medical Association AVMA Guidelines for the Eu-
thanasia of Animals (June 2007).
Electrophysiological recordings. IHCs and OHCs were identified visu-
ally by their characteristic shape and cell capacitance (7–12 pF). The
cochlear preparation was continuously superfused by means of a peri-
staltic pump (Gilson Minipulse 3, with 8 channels, Bioesanco) contain-
ing an extracellular saline solution of an ionic composition similar to that
of the perilymph as follows (in mM): 155 NaCl, 5.8 KCl, 1.3 CaCl2, 0.7
NaH2PO4, 5.6 D-glucose, and 10 HEPES buffer, pH 7.4. Working solu-
tions containing the different drugs and toxinsweremade up in this same
saline and delivered through the perfusion system. The pipette solution
was as follows (inmM): 150 KCl, 3.5MgCl2, 0.1 CaCl2, 5 EGTA, 5HEPES
buffer, and 2.5 Na2ATP, pH 7.2. Some cells were removed to access IHCs
and OHCs, but mostly the pipette moved through the tissue using posi-
tive fluid flow to clear the tip. Currents in IHCs andOHCswere recorded
in the whole-cell patch-clamp mode using an Axopatch 200A amplifier,
low-pass filtered at 2–10 kHz and digitized at 5–20 kHz with a Digidata
1322A board (Molecular Devices). Recordings were made at room tem-
perature (22–25°C). Glass pipettes, 1.2 mm inner diameter, had resis-
tances of 7–10 M. Recordings in OHCs were always performed at40
mV, since at this membrane potential, stable whole-cell recordings and a
good signal-to-noise ratio of the outward-going synaptic currents can be
obtained (Ballestero et al., 2011). Recordings in IHCs were performed at
90 mV with the exception of those in response to exogenously applied
ACh in which IHCs were voltage-clamped both at90 and at40 mV.
An outward-going current in response to ACh is expected at40 mV as
the ACh current is composed of an inward current flowing through the
910 nAChRs [reversal potential (Erev)  14 mV], plus the more
prominent outward current through the Ca2-activated SK2 potassium
channel (Erev  82 mV). At 90 mV, currents through these two
channels are inward (Oliver et al., 2000; Go´mez-Casati et al., 2005; Ball-
estero et al., 2011; Katz et al., 2011). The indicated holding potentials
were not corrected for liquid junction potentials (4 mV). Solutions
containing ACh or GABA (Fig. 1) were applied by a gravity-fed multi-
channel glass pipette (150mtip diameter) positioned at300mfrom
the recorded IHC or OHC.
Electrical stimulation of MOC efferent axons.Neurotransmitter release
was evoked by bipolar electrical stimulation of the medial olivocochlear
efferent axons as previously described (Goutman et al., 2005; Zorrilla de
San Martín et al., 2010). Briefly, the electrical stimulus was delivered via
a 20- to 80-m-diameter theta glass pipette placed at 20–60mmodio-
lar to the base of the recorded IHC or at the base of the IHC that was
aligned with the OHC under study. The position of the pipette was ad-
justed until postsynaptic currents in the IHCs or OHCs (voltage-
clamped at90 or40mV, respectively)were consistently activated. An
electrically isolated constant current source (model DS3, Digitimer Ltd)
was triggered via the data acquisition computer to generate pulses up to
30 mA for 200–2000 s.
Estimation of the quantum content of transmitter release. The quantum
content of transmitter release (m) was estimated as the ratio between the
mean amplitude of evoked (eIPSCs) and the mean amplitude of sponta-
neous IPSCs (sIPSCs;Del Castillo andKatz, 1954). To estimate the eIPSC
mean amplitude, 200 stimuli were applied at a frequency of 1 Hz. sIPSCs
were recorded during and after these 200 stimuli.
The percentage of quantum content (% m) after applying a drug or
toxin was calculated as follows:
mt
mc
 100,
where mc is the estimation of m in the control condition before drug
application to a given cell, andmt is the quantum content estimated after
incubation of the preparation with the drug or toxin under study for the
time specified in the Results section (treated preparations). The variabil-
ity in quantum content along the experiment in the absence of drug
(considered as the control for each experiment, Control % m), was cal-
culated comparing the quantum content at 10 min with that at 5 min
after break-in for each cell and expressed as a percentage.
As the frequency of sIPSCs is extremely low in OHCs (Ballestero et
al., 2011), m was calculated by the failures method (mf  ln N/N0),
where N0 is the number of failures and N is the total number of
successive trials (200 trials at a frequency of 1 Hz; Hubbard et al.,
1969). Failures of release were computed in the absence or presence of
the different drugs or toxins.
Statistical significance was evaluated by paired Student’s t test (one-
tailed) unless otherwise stated. A p 0.05 was considered significant. All
datawere expressed as themean SEM. Synaptic currents were analyzed
with Minianalysis (Synaptosoft) and Clampfit 9.2 (Molecular Devices).
Cochlear immunohistochemistry. Whole cochleae were dissected and
immediately perfused through the round window with 4% paraformal-
dehyde (PFA) in PBS, pH 7.4. Cochleae were fixed in 4% PFA overnight
at 4°C before rinsing with PBS. Apical turns of the organs of Corti were
excised from the cochleae and blocked in blocking buffer (PBS with 5%
normal goat serum and 0.3%Triton X-100) for 2 h at room temperature.
Cochlear apical turns were incubated with the primary antibody diluted
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in blocking buffer overnight at 4°C, rinsed three times for 20 min in PBT
(PBS with 0.3% Triton X-100), incubated with the secondary antibody
diluted in blocking buffer overnight at 4°C, rinsed three times for 20min
in PBT, and rinsed in PBS before mounting on glass slides in Vectashield
mounting medium (Vector Laboratories). A laser scanning confocal mi-
croscope (Fluoroview,Olympus)was used to acquire images of thewhole
mounted organs of Corti.
The following antibodies were used: rabbit anti-GFP (1:1000; Invitro-
gen), rabbit anti-glutamic acid decarboxylase (GAD; 1:500; Synaptic Sys-
tems), mouse anti-synaptophysin (1:1000; Millipore), and secondary
Alexa Fluor 488- and 568-labeled antibodies (1:1000; Invitrogen).
Drugs and toxins. Stock solutions of peptide toxins were prepared in
water.Drugs and reagentswere fromSigma-Aldrich,-conotoxin-GVIA
was from Alomone Labs; and -agatoxin-IVA (-AgaIVA) was from
Peptides International Inc.. All drugs and toxins were thawed and diluted
in the extracellular solution shortly before use.
Results
Effects of exogenously applied GABA to OHCs and IHCs
We first evaluated whether GABA is able to elicit postsynaptic
currents in mouse cochlear hair cells. GABA (1mM) was applied,
via a gravity-fed perfusion system, to voltage-clamped IHCs and
OHCs in the cochlear preparation. As a
positive control, we applied 1 mM ACh to
all evaluated cells (Fig. 1).
In P9–P11 IHCs, the age within the
short period at which these cells are inner-
vated by MOC efferent fibers (Glowatzki
and Fuchs, 2000; Simmons, 2002; Katz et
al., 2004; Guinan, 2011; Roux et al., 2011)
and at which both the number of func-
tionally innervated cells and their sensitiv-
ity to ACh are maximal (Katz et al., 2004;
Roux et al., 2011), 1 mM GABA failed to
elicit a postsynaptic current (n  3 cells,
two mice; Fig. 1A) when voltage-clamped
at40 mV. As under our recording con-
ditions the equilibrium potential for Cl
(ECl) is 0mV, we also tested the effects of
GABA at90 mV, which would enhance
a potential current carried by chloride
ions. As shown in the bottom of Figure
1A, GABA also failed to elicit currents in
IHCs voltage-clamped at this potential. In
the same cells 1 mM ACh evoked robust
currents at the two holding potentials
tested (226.6 50.2 pA at40mV, n 3;
and231.7 18.8 pA at90 mV, n 4;
Fig. 1A).
OHCs (P12–P16), the final targets of
MOC efferent innervation (Simmons et
al., 1996; Simmons, 2002), also lacked re-
sponses to 1 mM GABA when voltage-
clamped at 40 mV. In the same cells, 1
mM ACh consistently evoked robust out-
ward currents (129.0 21.84 pA; n 15
cells, 12 mice; Fig. 1B). The effects of
GABA in OHCs were only tested at 40
mV because these cells became very leaky
and unstable at90 mV (Ballestero et al.,
2011). These results clearly show that
IHCs and OHCs, at ages at which they
are functionally innervated by MOC ef-
ferent fibers, lack any GABAA receptor-
mediated responses.
Transmitter release at the MOC–IHC synapse is modified by
GABAB receptor compounds
In view of the lack of postsynaptic responses to exogenously ap-
plied GABA in hair cells, we asked whether GABA activates pre-
synaptic GABABRs to inhibit ACh release. Thus, we tested the
effects of GABABR-selective drugs on the quantum content of
transmitter release. Cholinergic postsynaptic responses evoked
with single shocks, at a stimulation frequency of 1 Hz, were mea-
sured in P9–P11 IHCs voltage-clamped at 90 mV. The quan-
tum content of evoked release (m) was obtained by calculating
the mean eIPSC amplitude in every cell and dividing it by the
mean sIPSC amplitude (Del Castillo and Katz, 1954). Under our
recording conditions, m was 1.2 0.2 (n 22 cells, 21 mice), a
value similar to that reported previously in IHCs from both rat
(Goutman et al., 2005) and mouse (Zorrilla de San Martín et al.,
2010) cochlear preparations. The quantum content of evoked
release, evaluated by 200 stimuli given at 1 Hz each 5 min, re-
mained constant during at least 60 min (data not shown). A 5–7
min incubation of the cochlear preparation with 1M baclofen, a
Figure1. Effects of exogenously appliedGABA to cochlear hair cells.A, Representative records obtained in IHCs at P9–P11upon
application of GABA and ACh; 1 mM GABA failed to evoke currents at either40 or90 mV in all IHCs tested. ACh, used as a
positive control, evoked currents at both potentials in all evaluated IHCs. B, Representative records obtained in OHCs at P12–P14
upon application of GABA andACh. In OHCs, 1mMGABA failed to evoke currents at40mV in all cells tested,whereas ACh evoked
currents in all evaluated cells. (Note that OHCs were voltage-clamped at40 mV and IHCs at both90 and40 mV; see
Materials and Methods for a detailed explanation of ACh-evoked currents.)
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selective GABABR agonist (Misgeld et al.,
1995), significantly reduced the amplitude
of eIPSCs (control: 39.7  6.1 pA, 1192
events, 8 cells, 6 mice; baclofen: 19.4 2.4
pA, 614 events, 8 cells, 7mice; unpairedStu-
dent’s t test, p 0.01; Fig. 2A), without af-
fecting the amplitude of sIPSCs (control:
11.00.9pA, 1651 events; baclofen: 12.0
1.6 pA, 759 events, p 0.24; Fig. 2A, right,
inset). Under these conditions, m was re-
duced to 74.4 6.9% and 57.07 8.3% of
the initial value (p 0.05), in the presence
of 0.3 and 1M baclofen, respectively [con-
trol: 126.6 12.3% for 0.3 M baclofen, 6
cells, 6 mice; and 91.2  7.1% for 1 M
baclofen, 8 cells, 7mice; Fig. 2B (the bars for
the respective control groups are not
shown); see Materials and Methods for ex-
planation of how % m was calculated for
both control and treated preparations]. As
illustrated in Figure 2C, baclofen signifi-
cantly reduced m in the eight cells tested
(control: 1.530.32; 1Mbaclofen: 0.87
0.23; p 0.01).
These results suggest that GABA regu-
lates the amount of ACh released at the
MOC–IHC synapse through the activation
of GABABR. To further test this hypothesis,
we studied the effects of CGP35348, a selec-
tive GABABR antagonist (Bittiger et al.,
1993; Fig. 3). CGP35348, at a concentration
of 1 M, significantly increased the ampli-
tude of eIPSCs after 5–7 min of incubation
(control: 25.4  11.6 pA, 617 events;
CGP35348: 28.5  5.9 pA, 664 events, 6
cells, 6 mice; p 0.05; Fig. 3A) without af-
fecting the amplitude of sIPCS (control:
14.85  0.49 pA, 558 events; CGP35348:
13.5  0.93 pA, p  0.08, 311 events; Fig.
3A, right, inset). Consistent with this result,
and in agreement with a presynaptic site
of action of CGP35348,m was significantly
increased by 1 M CGP35348 (control:
101.5 12.9%; CGP35348: 147.7 18%; 6
cells, 6 mice; p  0.05; Fig. 3B). The sum-
mary plots in Figure 3C show the six cells
tested, where 1 M CGP35348 signifi-
cantly increased m (control: 1.02  0.41;
CGP35348: 1.3 0.45; 6 cells, 6 mice; p
0.05). The fact that both baclofen and
CGP35348, theGABABRagonist andantag-
onist, respectively, significantly modified
the quantum content of evoked release,
strongly suggests that GABA inhibits the re-
lease of ACh through the activation of pre-
synaptic GABABR.
Baclofen failed to modify evoked
transmitter release at the MOC–IHC
synapse in mice lacking functional
GABABRs
To further explore the involvement of
GABABR in the release of ACh fromMOC
Figure 2. Baclofen, a specific GABABR agonist, reduces the quantum content of eIPSCs at the MOC–IHC synapse. A, Represen-
tative traces of eIPSCs recorded at a holding potential of90 mV before (left) and after 5 min of incubation with 1M baclofen
(right). The inset in A (right) shows that 1M baclofen (gray) did not affect the amplitude of sIPSCs. B, Bar graph showing that
baclofen (0.3 and 1M) caused a significant reduction inm. Results are expressed as a percentage of control. C, Summary plot for
individual cells recorded before (open circles) and after 5 min of incubation with 1M baclofen (filled circles). The mean SEM
values obtained before and after incubation with baclofen are plotted to the left and to the right of their respective individual
responses. *p 0.05, **p 0.01, paired Student’s t test.
Figure 3. CGP35348, a specific GABABR antagonist, increases the quantum content of eIPSCs at the MOC–IHC synapse. A,
Representative traces of eIPSCs recorded at a holding potential of90 mV before (left) and after 5 min of incubation with 1M
CGP35348 (right). The inset in A (right) shows that 1MCGP35348 (gray) did not affect the amplitude of sIPSCs. B, Bar graph
showing that CGP35348 caused a significant enhancement in m only at a concentration of 1 M. Results are expressed as a
percentage of control. C, Summary plot for individual cells recorded before (open circles) and after 5 min of incubation with 1M
CGP35348 (filled circles). Themean SEM values ofm obtained before and after incubationwith GCP35348 are plotted to the left
and to the right of their respective individual responses. *p 0.05, paired Student’s t test.
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efferent fibers contacting IHCs, we studied the effects of baclofen
in GABAB1 knock-out (1
/) mice lacking functional GABABRs
(Schuler et al., 2001; Bettler et al., 2004; Gassmann et al., 2004;
Gassmann and Bettler, 2012). Application of 1 M baclofen sig-
nificantly reducedm in wild-type (1/) mice (Fig. 4A, left; con-
trol: 109.4  10.4%; baclofen: 83.3  9.2%; 6 cells, 6 mice; p 
0.05), but not in 1/ littermate mice (Fig. 4B, left; control:
99.0 6.5%; baclofen: 93.8 8.1%; 6 cells, 6mice; p 0.32). No
significant differences were found in either sIPSC or eIPSC am-
plitude between wild-type and 1/mice (data not shown). The
summary plots for individual cells illustrate that 1 M baclofen
significantly reduced m in 1/ mice (control: 1.63  0.3;
baclofen: 1.33  0.21; 6 cells; p  0.05; Fig. 4A, right). How-
ever, baclofen did notmodify transmitter release (control: 1.04
0.20; baclofen: 0.95 0.16; 6 cells; p 0.13) in 1/mice (Fig.
4B, right). This result further supports the hypothesis that GABA
inhibits transmitter release at the MOC–IHC synapse by acting
through presynaptic GABABRs.
GABA inhibits the release of ACh at the MOC–IHC synapse
through presynaptic GABAB(1a,2)Rs
Functional GABABRs are heterodimers composed of theGABAB1
and GABAB2 subunits (Jones et al., 1998; Kaupmann et al., 1998;
White et al., 1998; Kuner et al., 1999). Molecular diversity of
GABABR arises from two different and pharmacologically indis-
tinguishable GB1 isoforms, 1a and 1b (Bettler et al., 2004). There
is evidence indicating that these two isoforms are expressed at
different synaptic sites, with GB1a predominantly located at the
presynapse and GB1b at the postsynapse
(Pe´rez-Garci et al., 2006; Vigot et al.,
2006).
TodeterminewhichGB1 isoform is in-
volved in the inhibition of ACh release at
theMOC–IHC synapse, we compared the
effects of baclofen in mutant mice lack-
ing either the GABAB1a (1a
/) or the
GABAB1b (1b
/) isoform (Vigot et al.,
2006; Fig. 5). Application of 1Mbaclofen
significantly reduced m at MOC–IHC
synapses from wild-type littermate mice
of both isoforms (1a/: Fig. 5A, left; con-
trol: 94.3 10.1%; baclofen: 64.6 8.8%;
10 cells, 8 mice; p 0.05; 1b/: Fig. 5C,
left; control: 102.5  8.1%; baclofen:
72.9  4.2%; 7 cells, 7 mice; p  0.01).
Baclofen did not modifym in 1a/mice
(Fig. 5B, left; control: 106.3  7.0%;
baclofen: 96.9  6.8%; 13 cells, 9 mice;
p  0.09), indicating that the GABAB1a
isoform inhibits transmitter release. On
the contrary, m was significantly reduced
in 1b/mice, excluding an involvement
of the GABAB1b isoform (Fig. 5D, left;
control: 113.4 10.5%; baclofen: 70.7
10.0%; 7 cells, 6mice; p 0.01). The right
panels in Figure 5A–D are the summary
plots for individual cells from each group
of mice recorded in control conditions
and after 7 min of incubation with 1 M
baclofen (Fig. 5A, 1a/: control, 1.60 
0.2; baclofen, 1.04  0.21; 10 cells; p 
0.01; Fig. 5B, 1a/: control, 1.56 0.25;
baclofen, 1.54  0.27; 13 cells; p  0.46;
Fig. 5C, 1b/: control, 1.33 0.2; baclofen, 0.92 0.1; 7 cells;
p  0.01; Fig. 5D, 1b/: control, 1.5  0.3; baclofen, 1.03 
0.27; 7 cells; p  0.01). Baclofen did not alter the amplitude of
sIPSCs in any of the GABABR knock-out mice (data not shown).
Together, our results strongly suggest that ACh release at the
MOC–IHC synapse is inhibited by GABA acting on presynaptic
GABAB1a-containing receptors, the GABAB(1a,2)Rs.
P/Q-type VGCCs are inhibited following GABABR activation
We have recently shown that both P/Q- and N-type VGCCs
support neurotransmitter release at the mouse MOC–IHC
synapse before the onset of hearing (Zorrilla de San Martín et
al., 2010). To gain insight into the mechanisms underlying the
inhibition that GABA exerts on ACh release at this synapse, we
tested the effects of the GABAB antagonist CGP35348 in the
presence of blockers of P/Q- and N-type VGCCs, -AgaIVA,
and -conotoxin GVIA (-CgTx), respectively.
As previously reported (Zorrilla de SanMartín et al., 2010),m
was greatly reduced after 15 min of incubation with 200 nM
-AgaIVA (Fig. 6A,B; control: 1.20  0.14; 9 cells, 9 mice;
-AgaIVA: 0.26  0.1; 11 cells, 9 mice; p  0.001). Under this
condition, CGP35348 failed to significantly increase the amount
of transmitter released by the MOC fibers (Fig. 6A,B; CGP:
0.34 0.1; 9 cells, 9 mice; p 0.07). The inset in Figure 6 shows
representative averaged traces illustrating the effects of
-AgaIVA and CGP35348 on the amplitude of eIPSCs. sIPSCs
were not affected by either of these drugs (data not illustrated;
control: 9.33  0.4 pA; -AgaIVA: 8.6  0.3 pA; CGP: 8.4 
Figure 4. Baclofen fails to reduce the quantum content of eIPSCs at theMOC–IHC synapse inmice lacking functional GABABRs.
A, B, Left, Bar graphs showing that 1 M baclofen reduced m in wild-type mice (1/, A) but not in mice lacking functional
GABABRs (1
/, B). Results are expressed as a percentage of control. A, B, Right, Summary plots for individual cells recorded
before (open circles) andafter 5minof incubationwith 1Mbaclofen (filled circles) in 1/ (A) and1/mice (B). Themean
SEM values of m obtained before and after incubation with baclofen are plotted to the left and to the right of their respective
individual responses. *p 0.05 paired Student’s t test.
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0.4 pA; 9 cells, 9 mice; ANOVA, p 0.17; n 179, 123, and 104
events, respectively).
Figure 6D and E, shows that m was, as previously reported
(Zorrilla de SanMartín et al., 2010) significantly reduced after 15
min of incubation with 500 nM -CgTx (control: 0.73  0.1; 7
cells, 7 mice; -CgTx; 0.35  0.1; 13 cells, 11 mice; p  0.001).
Under this condition, 1 M CGP35348 was still able to signifi-
cantly increase m when compared with the -CgTx-treated
group (CGP: 0.51  0.1; 10 cells, 8 mice; p  0.05). Figure 6,
inset, shows representative averaged traces illustrating the effect
of -CgTx and CGP35348 on the amplitude of eIPSPs. sIPSC
amplitude was not affected by -CgTx or -CgTxCGP (data
not illustrated; control: 11.1  0.2 pA; -CgTx: 11.5  0.3 pA;
CGP: 10.9 0.2 pA; 7 cells, 7mice; ANOVA, p 0.21, n 300,
210, and 185 events, respectively). Together, these results suggest
that the activity of P/Q-type VGCCS is reduced following
GABABR activation.
GABA regulates the release of ACh at the MOC–OHCs
synapse through inhibitory presynaptic GABABRs
At the beginning of the second postnatal week, OHCs begin to
respond to ACh (Dulon and Lenoir, 1996; He and Dallos, 1999).
To determine whether GABA exerts an inhibitory effect on ACh
release at these synapses, we tested the effects of the GABABR
antagonist CGP35348 on the quantum content of evoked release
at theMOC–OHC synapse (Fig. 7). As the frequency of sIPSCs at
MOC–OHC synapses is very low,mwas evaluated by the failures
method (see Materials and Methods).
Representative traces of eIPSCs recorded in OHCs (P14) be-
fore (Fig. 7A) and after (Fig. 7B) incubating the cochlear prepa-
ration with 1 M CGP35348 show that the number of failures
decreased in the presence of the antagonist. Consistently, ACh
release was significantly enhanced in the presence of the antago-
nist (Fig. 7C; control: 111.0 26.6%; CGP35348: 170.4 37.5%;
4 cells, 3 mice; p 0.05). The summary plot in Figure 7D shows
that m significantly increased in the four cells tested after incu-
bating the cochlear preparation with CGP35348 (control: 0.12
0.02; CGP35348: 0.29  0.04; p  0.01). These results indicate
that GABA inhibits ACh release at the MOC–OHC synapse
through the activation of presynapticGABABRs. In a futurework,
experiments will be carried out to test whether ACh release at the
MOC–OHC synapse is also inhibited by GABA acting on presyn-
aptic GABAB(1a,2)Rs.
GABABRs are expressed in efferent synaptic terminals at the
base of IHCs and OHCs before the onset of hearing
The electrophysiological experiments shown above demonstrate
that synaptic activation of GABABRs inhibits ACh release at both
MOC–IHC and MOC–OHC synapses. To confirm the expres-
sion of GABABRs at the terminals of these synapses, we used a
transgenic mouse line (GABAB1-GFP) in which GFP is fused to
the GABAB1 subunit (Casanova et al., 2009; Fig. 8). Cochlear
whole-mount preparations from P9–P14 were coimmunos-
tained with GFP antibodies to enhance the endogenous GFP
signal and to detect GFP-tagged GABAB1 subunits and synapto-
physin antibodies to identify efferent terminals contacting hair
Figure 5. Baclofen fails to reduce the quantum content of eIPSCs at the MOC–IHC synapse in mice lacking the 1a GABABR isoform. A–D, Quantum content of eIPSC recorded in IHCs, evoked by
electrical stimulation of theMOC efferent axons before and after incubationwith 1M baclofen in wild-type (A, C) and in isoform-specific GABAB knock-outmice: 1a
/) inB; 1b/ inD. In the
bar graphs, results are expressed as a percentage of control. Summary plots for individual cells recorded before and after 7min of incubationwith 1M baclofen are shown on the right in A–D. The
mean SEMvalues ofm obtained before and after incubationwith baclofen are plotted to the left and to the right of their respective individual responses. *p 0.05, **p 0.01, paired Student’s
t test.
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cells. A GABAB1-GFP-positive signal was detected in the inner
spiral bundle region at the base of IHCs containing both efferent
and type I afferent neurons. A strong colocalization of GFP
with synaptophysin was observed, indicating the presence of
GABABRs at efferent terminals under the IHCs (Fig. 8A–C). In
the OHC region, GABAB1 expression was found both in type II
afferent and MOC efferent fibers contacting the OHCs (Fig. 8C,
inset, filled arrow). The expression of GABABRs at MOC termi-
nals suggests the presence of the neurotransmitter GABA at the
synapse. To study whether GABA is present at efferent terminals
contacting hair cells at ages around the onset of hearing, we used
an antibody that recognizes the GABA synthetic enzyme GAD
(Fig. 8D–F) together with an antibody recognizing synaptophy-
sin. In regions below IHCs and OHCs, GAD colocalized with
synaptophysin (Fig. 8F, inset, filled arrow). These immunostain-
ings are consistent with our electrophysiological results showing
that GABA is involved in the modulation of synaptic transmis-
sion at MOC–hair cell efferent synapses during development.
Discussion
Lack of GABA postsynaptic effects
The present results show that GABA failed to elicit postsynaptic
currents in either OHCs or IHCs. This suggests that, at least in
mid-apical cochlear turns from P9–P16 mice, there are no func-
tional postsynaptic GABAA receptors at either theMOC–OHCor
the MOC–IHC synapse. The discrepancy with a report showing
that application of GABA hyperpolarizes OHCs (Gitter and Ze-
nner, 1992) might be explained by differences in species (guinea
pigs vsmice) and/or age (adult vs P12–P16) of the animals used in
the experiments. The absence of postsynaptic GABAA-mediated
responses is consistent with the observation that when the910
nAChR is pharmacologically blocked, no postsynaptic currents
in response to either K elevation or electrical stimulation of the
MOC efferent axons are seen in OHCs (Oliver et al., 2000; Ball-
estero et al., 2011) and IHCs (Glowatzki and Fuchs, 2000).More-
over, it is in line with the finding that in 9 knock-out mice, no
postsynaptic currents are left (Vetter et al., 2007), clearly indicating
that fast synaptic transmission at theOC–hair synapse is cholinergic
and mediated only through the 910 nAChR (Fig. 9). Moreover,
the fact that GABAB receptors are not expressed either in postnatal
(present work) or adult hair cells (Maison et al., 2009) further sug-
gests a lack of a postsynaptic GABAB-mediated action. Together,
these results support the idea that themain effect of the profuse OC
GABAergic innervation thatmakes direct synaptic contacts with co-
chlear hair cells is not a postsynaptic one.
GABAmodulates transmitter release at MOC–hair cell
synapses through GABAB(1a,2)Rs
The results obtained with the GABABR agonist and antagonist
indicate that GABA inhibits ACh release at MOC–hair cell
Figure6. P/Q-type Ca 2channels are the target of GABAB receptor activation at the transientMOC–IHC synapse.A,B, Bar diagram (A) and the plot of individual cells (B) show the effects of 1M
CGP35348 onm after blocking P/Q-type VGCCswith 200 nM-agatoxin-IVA. Inset betweenA andB illustrates representative averaged traces showing the effects of CGP on the amplitude of eIPSPs
in the presence of-agatoxin-IVA (control, black;-Aga, gray;CGP, red). C,D, Bar diagram (C) and plot of individual cells (D) illustrating the effect of 1MCGP35348 on transmitter release after
blocking N-type VGCCswith 500 nM-conotoxin GVIA. Inset between graphs illustrates representative averaged traces showing the effects of CGP35348 on the amplitude of eIPSPs in the presence
of-conotoxin GVIA (control, black;-CgTx, gray;CGP, red). Red horizontal bars in B and D represent the mean in each group. Error bars represent the SEM. *p 0.05, ***p 0.001, paired
Student’s t test.
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synapses through presynaptic GABABRs.
These results are in agreement with the
classical role of GABA in presynaptic
modulation of synaptic transmission at
mammalian glutamatergic and GABAer-
gic synapses via heteroreceptors and auto-
receptors, respectively (Gaiarsa et al.,
1995; Brenowitz et al., 1998; Chalifoux
and Carter, 2011; Fischl et al., 2012). The
modulation of ACh release, as described
in the present work, although not widely
observed, is not without precedent. For
example, the activation of presynaptic
GABABRs inhibits ACh release from Cae-
norhabditis elegans motoneurons (Schul-
theis et al., 2011) and from cholinergic
nerve terminals in the rat superior cervical
ganglion (Farkas et al., 1986). However,
the present results are unique due to the
inhibitory sign of the cholinergic OC–
hair cell synapse. Thus, the release of
GABA at the inhibitory mammalian
cholinergic synapse activates presynaptic
GABABRs that inhibit the release of ACh
and therefore curtail inhibition.
The lack of effect of baclofen in mice
with a specific ablation in the GB1a
(1a/) subunit isoform (Vigot et al.,
2006) clearly demonstrates the involve-
ment of the GB1a isoform in the presyn-
aptic inhibition of ACh release at the
MOC–IHC synapse. This is in agreement
with the established role of GABAB1a in
presynaptic inhibition (Gassmann and
Bettler, 2012). For example, at glutama-
tergic hippocampal CA3–CA1 synapses,
GABAB1amainlyassembles intopresynaptic
heteroreceptors, while receptors formed by
the GABAB1b subunit mediate postsynaptic
inhibition (Vigot et al., 2006). Similarly,
presynaptic inhibition at GABAergic syn-
apses between synaptic terminals fromneu-
rons in cortical layer 1 and pyramidal
neurons in cortical layer 5 is absent in the
1a/butnot in the1b/mice, suggesting
thatGABAB1abutnotGABAB1b subunits as-
semble into presynaptic autoreceptors
(Pe´rez-Garci et al., 2006). Our findings at a
cholinergic synapse thus provide further ev-
idence for distinct physiological roles and a
differential distribution of GABAB1 subunit
isoforms.
GABABRs negatively regulate synaptic
transmission at the MOC–IHC synapse
by inhibiting P/Q-type VGCCs
At the MOC–IHC synapse, ACh release is
mediated by both N- and P/Q-type
VGCCs (Zorrilla de San Martín et al., 2010). At several central
synapses, presynaptic GABABRs reduce transmitter release by di-
rect inhibition of P/Q- and N-type VGCCs through G sub-
units of the activated G-protein (Mintz and Bean, 1993;
Thompson et al., 1993; Lambert andWilson, 1996; Bowery et al.,
2002; Bettler et al., 2004). The fact that the GABABRs antagonist
CGP35348 failed to significantly increase transmitter release at
the MOC–IHC synapse when P/Q-type VGCCs were completely
blocked by -agatoxin-IVA, together with the observation that
CGP353548 increased transmitter release after blocking N-type
Figure 7. CGP35348 increases the quantum content of transmitter release at the MOC–OHC synapse. A, B, Representative
traces of eIPSCs recorded in OHCs at40 mV, before and after incubation with 1M CGP35348. C, Bar diagram showing that
CGP35348 (1M) significantly increasedmat theMOC–OHCsynapse. Results are expressedas apercentageof control.D, Summary
plot for individual cells recordedbeforeandafter 15minof incubationwith1MCGP35348. ThemeanSEMvaluesofmobtained
before and after incubation with CGP35348 are plotted to the left and to the right of their respective individual responses. *p
0.05, **p 0.01, paired Student’s t test.
Figure 8. GABABRs are expressed in efferent synaptic terminals at the base of IHCs and OHCs. A–C, Cochlear whole-
mount preparations from P9 to P14 double-immunostained with anti-GFP; A, green), and synaptophysin (Syn; B, red). A
strong colocalization of GFP with synaptophysin can be observed (C, yellow) in the inner spiral bundle region at the base of
IHCs (efferent and type I afferent neurons) and, at the OHC region, in type II afferent and MOC efferent fibers contacting the
cells (C, filled arrow). D–F, cochlear preparations from similar aged mice immunostained with an antibody to the GABA
synthetic enzyme GAD (D, green) together with synaptophysin (E, red). F, Immunoreactivity is visible as small puncta
below IHCs (filled arrow) and OHCs indicating that GAD colocalized with synaptophysin at these regions (yellow). ISN, Inner
spiral bundle; OSB, outer spiral bundle.
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VGCCs with -conotoxin GVIA, indicates that P/Q- and not
N-type VGCCs are inhibited by GABABR activation (Fig. 9).
However, our results do not exclude the participation of other
proteins in the GABAB signaling cascade, like L-type VGCCs
(Shen and Slaughter, 1999; Zorrilla de San Martín et al., 2010;
Bray andMynlieff, 2011) and like proteins of the vesicular release
machinery downstream of VGCCs (Yoon et al., 2007).
GABABRs are expressed in efferent synaptic terminals at the
base of IHCs and OHCs
The electrophysiological data suggest the presence of func-
tional GABABRs at MOC synaptic terminals contacting both
the IHCs and OHCs. Immunostaining experiments in trans-
genic GABAB1-GFP mice further demonstrate the expression
of GABABRs in OC terminals contacting these cells. In the IHC
area, the GABAB1-GFP immunostaining arising from the OC
terminals could, in principle, derive from the LOC fibers con-
tacting type I afferent dendrites, the MOC fibers that tran-
siently innervate the IHCs, or both (Liberman et al., 1990;
Vetter et al., 1991; Simmons, 2002; Maison et al., 2003). Our
electrophysiological data, however, rule out the possibility
that GABABRs are solely expressed in the LOC fibers innervat-
ing the afferent neurons and clearly demonstrate that func-
tional GABABRs are present at the MOC synaptic terminals
making axo-somatic synapses with IHCs.
The lack of GFP immunostaining in OHCs and IHCs, and the
presence of GFP immunostaining in type I and type II afferent
fibers in GABAB1-GFP mice during development replicate the
findings that were made with adult mice (Maison et al., 2009). In
addition, this agrees with the presence of GABABR transcripts in
mouse spiral ganglion neurons from embryonic through adult
stages (Lin et al., 2000). Interestingly, in adult mice, GABABRs
were not detected in OC efferent terminals in either the IHC or
theOHCareas (Maison et al., 2009). Together, the present results
and those of Maison et al. (2009) suggest that the OC efferent
synaptic terminals transiently express GABABRs. Moreover, the
results imply that GABABRs are expressed in type I and type II
afferent fibers before the onset of hearing and remain there
through adulthood. In contrast, GABABRs expressed in OC
terminals are downregulated between the onset of hearing and
adulthood. Downregulation of GABABR during development,
most prominently the GABAB1a isoform, has been described
(Malitschek et al., 1998; Bianchi et al., 2005). Interestingly, the
expression of two postsynaptic key molecules of the transient
MOC–IHC synapse, the 10 nAChR subunit and the SK2 K
channel, also cease to express around the onset of hearing
(Katz et al., 2004), further highlighting the importance of co-
chlear synaptic refinement during the critical period (Sim-
mons et al., 1996).
Functional consequences
Our functional data, together with the immunodetection of
GABAB receptors at OC terminals and of GAD in fibers reveal
the existence of GABAergic OC fibers contacting IHCs and
OHCs around the onset of hearing. These results are in agree-
ment with the notion that the only source of GABAergic input
to the mammalian cochlea is the OC system (Fex and
Altschuler, 1986; Thompson et al., 1986; Vetter et al., 1991;
Eybalin, 1993; Maison et al., 2003). Moreover, our functional
data suggest that GABA and ACh are both released uponMOC
fiber activity (Fig. 9). Based on the observations that in adult
mice GABA and ACh are colocalized in the same terminals
(Maison et al., 2003), we hypothesize that both neurotrans-
mitters are coreleased upon efferent activation. Corelease of
GABA and ACh, two fast neurotransmitters of usually oppo-
site excitability, from the same terminal has been described for
the retinal starburst amacrine cells (Duarte et al., 1999; Lee et
al., 2010), where both neurotransmitters act at postsynaptic
receptors. However, a different scenario is observed at the
OC–hair synapse, where ACh release might be regulated by
coreleased GABA acting at GABAB autoreceptors.
Presynaptic inhibition of ACh release via GABABRs might
shape short-term plasticity properties of the MOC–hair cell
synapses by regulating the release probability and, thus, as
reported for other synapses (Brenowitz et al., 1998; Brenowitz
and Trussell, 2001), allow continuous signaling upon high-
frequency MOC activity. Since MOC firing frequency in-
creases with sound intensity (Robertson and Gummer, 1985;
Brown, 1989) and the efficacy of the MOC–IHC synapse is
optimal when MOC fibers are activated at high frequency
(Ballestero et al., 2011), presynaptic inhibition might there-
fore be relevant for MOC protection from acoustic trauma
(Rajan, 2000; Taranda et al., 2009).
Conclusions
Synaptic strength is a key variable during development for both
establishing and refining connections. Our results show that dur-
ing the development of the auditory system GABA inhibits the
amount of ACh released at the MOC–hair cell synapse through
presynaptic GABAB(1a,2)Rs, coupled to P/Q-type VGCCS. Thus,
we demonstrate that GABA regulates the strength of the MOC–
IHC synapse, and could thereby control the IHC firing frequency,
and, therefore, the release of glutamate in the first auditory syn-
apse at a critical period where synaptic connections are actively
being formed in the cochlea, also a period where the entire audi-
tory pathway is being established.
Figure 9. Schematic representation of the ion channels and receptors that support
and regulate transmitter release from the MOC efferent synaptic terminals. After invasion
of the terminal action potential, Ca 2 entering through both P/Q- and N-type VGCCs
supports the release of ACh, while L-type VGCCs exert a negative control on this process by
activating BK channels (Zorrilla de San Martín et al., 2010). The present results strongly
suggest that GABA, coreleased with ACh, activates presynaptic GABAB(1a,2)Rs, which neg-
atively regulate the release of ACh by altering Ca 2 influx through P/Q-type VGCCs.
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